407317001: Adalimumab (substance)

SNOMED CT Concept\Substance\...

\Substance categorized by disposition\Immunomodulator\Tumor necrosis factor alpha inhibitor\Adalimumab (substance)

\A grouper concept for substances that are used in medicinal products for medical treatment, and also psychoactive substances that have few or no legitimate medical uses or that are not legally available to the person using them.\Tumor necrosis factor alpha inhibitor\Adalimumab (substance)
\A grouper concept for substances that are used in medicinal products for medical treatment, and also psychoactive substances that have few or no legitimate medical uses or that are not legally available to the person using them.\Immunologic agent (substance)\Adalimumab (substance)
\A grouper concept for substances that are used in medicinal products for medical treatment, and also psychoactive substances that have few or no legitimate medical uses or that are not legally available to the person using them.\Monoclonal antibody\Adalimumab (substance)

\Substance categorised by structure\Chemical\Chemical categorized by structure (substance)\...

\Nitrogen and/or nitrogen compound (substance)\Nitrogen compound\Organic nitrogen compound\Amide and/or amide derivative (substance)\Substituted amide (substance)\Polypeptide\Protein\Antibody\Monoclonal antibody\Adalimumab (substance)

\Organic compound\Organic nitrogen compound\Amide and/or amide derivative (substance)\Substituted amide (substance)\Polypeptide\Protein\Antibody\Monoclonal antibody\Adalimumab (substance)

\Biological substance\Protein and/or protein derivative\Protein\Antibody\Monoclonal antibody\Adalimumab (substance)
\Biological substance\Immunologic substance\Antibody\Monoclonal antibody\Adalimumab (substance)
\Biological substance\Polypeptide\Protein\Antibody\Monoclonal antibody\Adalimumab (substance)

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2004. Module: SNOMED CT core

Descriptions:

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Adalimumab (substance)	Is a	agent d'anticorps monoclonal	false	Inferred relationship	Some
Adalimumab (substance)	Is a	agent antirhumatismal	false	Inferred relationship	Some
Adalimumab (substance)	Is a	Tumor necrosis factor alpha inhibitor	true	Inferred relationship	Some
Adalimumab (substance)	Is a	Monoclonal antibody	true	Inferred relationship	Some
Adalimumab (substance)	This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context.	Tumor necrosis factor alpha inhibitor (disposition)	true	Inferred relationship	Some
Adalimumab (substance)	Is a	Immunologic agent (substance)	true	Inferred relationship	Some

Inbound Relationships	Type	Active	Source	Characteristic	Refinability	Group
Adalimumab 40mg injection solution 0.8mL prefilled syringe	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Adalimumab (substance)	Inferred relationship	Some
Product containing adalimumab (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Adalimumab (substance)	Inferred relationship	Some	1
Adalimunab 40mg/mL injection solution 1mL prefilled syringe	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Adalimumab (substance)	Inferred relationship	Some
Adalimumab therapy (procedure)	Direct substance	True	Adalimumab (substance)	Inferred relationship	Some	2
Product containing precisely adalimumab 40 milligram/0.8 milliliter conventional release solution for injection syringe	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	False	Adalimumab (substance)	Inferred relationship	Some	1
Product containing precisely adalimumab 40 milligram/0.8 milliliter conventional release solution for injection syringe	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	False	Adalimumab (substance)	Inferred relationship	Some	1
Product containing adalimumab in parenteral dose form (medicinal product form)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Adalimumab (substance)	Inferred relationship	Some	1
Product containing only adalimumab (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Adalimumab (substance)	Inferred relationship	Some	1
Adalimumab only product in parenteral dose form	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Adalimumab (substance)	Inferred relationship	Some	1
Adalimumab 50 mg/mL solution for injection	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Adalimumab (substance)	Inferred relationship	Some	1
Adalimumab 50 mg/mL solution for injection	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Adalimumab (substance)	Inferred relationship	Some	1
Product containing precisely adalimumab 100 milligram/1 milliliter conventional release solution for injection (clinical drug)	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Adalimumab (substance)	Inferred relationship	Some	1
Product containing precisely adalimumab 100 milligram/1 milliliter conventional release solution for injection (clinical drug)	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Adalimumab (substance)	Inferred relationship	Some	1

This concept is not in any reference sets

Back to Start

Id	Description	Lang	Type	Status	Case?	Module
2151148012	Adalimumab (substance)	en	Fully specified name	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
2158924011	Adalimumab	en	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
56931000195118	adalimumab	it	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT Switzerland NRC maintained Module
193121000077110	adalimumab	fr	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT Switzerland NRC maintained Module
72011000195112	Adalimumab	de	Synonym (core metadata concept)	Active	Entire term case sensitive (core metadata concept)	SNOMED CT Switzerland NRC maintained Module